Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kevin Lillehei to Neoplasms

This is a "connection" page, showing publications Kevin Lillehei has written about Neoplasms.

 
Connection Strength
 
 
 
0.267
 
  1. Kong Q, Beel JA, Lillehei KO. A threshold concept for cancer therapy. Med Hypotheses. 2000 Jul; 55(1):29-35.
    View in: PubMed
    Score: 0.069
  2. Lillehei KO, Liu Y, Kong Q. Current perspectives in immunotherapy. Ann Thorac Surg. 1999 Sep; 68(3 Suppl):S28-33.
    View in: PubMed
    Score: 0.065
  3. Kong Q, Lillehei KO. Antioxidant inhibitors for cancer therapy. Med Hypotheses. 1998 Nov; 51(5):405-9.
    View in: PubMed
    Score: 0.061
  4. Mayer-Sonnenfeld T, Har-Noy M, Lillehei KO, Graner MW. Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure. Int J Hyperthermia. 2013 Sep; 29(6):520-7.
    View in: PubMed
    Score: 0.042
  5. Lillehei KO, Donson AM, Kleinschmidt-DeMasters BK. Radiation-induced meningiomas: clinical, cytogenetic, and microarray features. Acta Neuropathol. 2008 Sep; 116(3):289-301.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)